SEC Tracker
Get the app

Orchestra BioMed Holdings OBIO

Eric S Fain (Director) plans to sell 1,800 OBIO shares, about $9,774

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Sep 9, 2024
  2. Broker: Fidelity Brokerage Services LLC
  3. Shares acquired by: Restricted Stock Vesting

All of Eric S Fain's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Orchestra BioMed Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Myomo MYO public float $62M, Jun 30, 2025
  2. Edap TMS EDAP public float $62M, Jun 30, 2025
  3. InspireMD NSPR public float $61M, Jun 30, 2025
  4. Cytosorbents CTSO public float $61M, Jun 30, 2025
  5. Pro Dex PDEX public float $68M, Dec 31, 2025

Data on this page was fetched . The filing on SEC.gov is the record.